Cerebral quantitative susceptibility mapping predicts amyloid-β-related cognitive decline.
Ayton S, Fazlollahi A, Bourgeat P, Raniga P, Ng A, Lim YY, Diouf I, Farquharson S, Fripp J, Ames D, Doecke J, Desmond P, Ordidge R, Masters CL, Rowe CC, Maruff P, Villemagne VL; Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group; Salvado O, Bush AI.
Ayton S, et al. Among authors: farquharson s.
Brain. 2017 Aug 1;140(8):2112-2119. doi: 10.1093/brain/awx137.
Brain. 2017.
PMID: 28899019